Le Lézard
Classified in: Science and technology, Business
Subjects: SLS, RCN

Mobvista Announces 2022 Interim Financial Report


Revenue exceeds $456 million, up 48% year-on-year, and an adjusted EBITDA up by 162% year-on-year.

GUANGZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Mobvista, a leading technology platform providing a unified stack of SaaS products and services, today announced its 2022 interim financial results, including revenue of $456 million in H1 2022, a 48% year-on-year increase, and an adjusted EDITBA of $5.824 million, up 162% year-on-year. Additionally, Mobvista's net revenue after deducting costs allocated to publishers achieved $111 million, a year-on-year increase of 99.5%.

The steady growth in performance was attributable to the stable performance of Mintegral, Mobvista's programmatic advertising platform. During the reporting period, Mintegral achieved revenue of $410 million, a year-on-year increase of 82.8%. As of Q2 2022, the number of new partnered advertisers increased 29.3% from the previous quarter, with an advertiser retention rate of 87.7%. In addition, the number of new partnered publishers increased by 19% from the previous quarter, with a 92.2% publisher retention rate.

At the same time, Mintegral has diversified its customer vertical base beyond gaming to include a higher share of eCommerce, social and content, lifestyle, and utility apps, among others. Through this approach, Mintegral's revenue growth rate under utility apps skyrocketed by 862.2% in the first half of 2022.

The customer value of Mintegral's retained customers has also increased significantly. For the twelve months leading up to June 30th, 2022, the company's dollar-based net expansion rate was 197.5%, reflecting the significant increase in the value of existing customers.

Mobvista has also carried out strategic restructuring by shrinking non-core businesses to optimize business operations. These measures have helped Mobvista record a gross profit of $89.98 million, a year-on-year increase of 112%.

About Mobvista

Mobvista is a leading technology platform dedicated to driving global business growth in the digital age. Mobvista's goal is to build a SaaS tooling ecosystem that includes products and solutions for mobile marketing, data analytics, creative automation, monetization, and elastic cloud cost optimization. Mobvista aims to be the catalyst that connects China and the rest of the world by helping customers build ambitious business models and drive business growth.

Mobvista was founded in Guangzhou, China, in 2013 and has been listed on the Main Board of the Stock Exchange of Hong Kong (01860.HK) since December 2018. Mobvista has close to 1000 employees with offices in 17 cities worldwide.

SOURCE Mobvista


These press releases may also interest you

at 07:20
Global Blue Group Holding AG (the "Company") has continued to demonstrate a robust recovery, underpinned by the entrenched behaviour of travel and shopping, driving significant EBITDA and cash flow growth. Consequently, net leverage reduced from...

at 07:18
BlueHalo, the company transforming the future of global defense, and Kraken Technology Group, a maritime technology leader specializing in disruptive high-performance platforms, today announced a strategic partnership to integrate BlueHalo's...

at 07:05
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...

at 07:05
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available...

at 07:05
FiscalNote Holdings, Inc. ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of global policy and market intelligence, today announced that members of the senior management team will be participating in the following upcoming...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC)...



News published on and distributed by: